Valuation in 2020 wasn't just another year. It was the year the models broke — or at least bent until people stopped trusting them.
If you worked in corporate finance, M&A, or financial reporting that year, you remember the scramble. March hit and suddenly every DCF model had a gaping hole where "terminal value" used to be. Comparable company analysis? Day to day, the comps were trading at multiples that made no sense one week and different nonsense the next. Precedent transactions dried up. Deals got retraded. Fair value measurements for ASC 820 and IFRS 13 became exercises in creative writing That alone is useful..
This post isn't a textbook recap. It's a field guide to what actually happened in valuation during 2020 — the methodologies that held up, the ones that didn't, and what practitioners learned (or should have learned) when the world turned upside down It's one of those things that adds up. Still holds up..
What Valuation Looked Like in 2020
Valuation in 2020 was defined by one thing: unprecedented uncertainty. Think about it: not the "we don't know if growth will be 3% or 4%" kind. The "we don't know if this business exists in six months" kind The details matter here. Which is the point..
The standard toolkit — DCF, trading comps, precedent transactions, asset-based approaches — didn't disappear. But the inputs became unreliable. Revenue forecasts were guesses. EBITDA margins were distorted by one-time items (PPP loans, rent abatements, supply chain chaos). Here's the thing — discount rates? The risk-free rate plummeted while equity risk premiums spiked. Beta became meaningless for companies whose stock charts looked like EKGs Simple, but easy to overlook. Took long enough..
Practitioners had to adapt. Fast.
The big shift: from point estimates to scenario-based valuation
Pre-2020, most valuation reports centered on a single base case with a sensitivity table tacked on at the end. In 2020, the sensitivity table became the valuation. Scenario analysis — bear, base, bull — moved from appendix to center stage. Probability-weighted scenarios replaced single-point estimates in purchase price allocations, impairment testing, and fairness opinions That alone is useful..
Real talk — this step gets skipped all the time.
Some firms went further: Monte Carlo simulations, real options analysis, and decision trees started showing up in places they rarely lived before — middle-market M&A, not just pharma or oil & gas The details matter here..
The "COVID adjustment" problem
Every valuation in 2020 wrestled with the same question: how do you separate COVID impact from business fundamentals?
- Revenue: Was the drop temporary (demand destruction) or permanent (behavior change)?
- Margins: Were cost cuts structural or survival-mode?
- Cash flow: How much was propped up by government stimulus (PPP, ERC, EIDL, furlough schemes globally)?
- Working capital: Payables stretched, receivables delayed, inventory piled up or stocked out.
There was no standard playbook. Think about it: the AICPA, PCAOB, IVSC, and major valuation firms all issued guidance — but it was framework, not formula. Judgment calls varied wildly. Two valuators looking at the same restaurant chain in June 2020 could justify a 40% difference in value just by disagreeing on "when does indoor dining normalize?
Why 2020 Still Matters for Valuation Today
You might think: that was a weird year, move on. But 2020 rewired how valuation gets done. The habits formed then — scenario modeling, explicit disclosure of key assumptions, stress-testing inputs — are now table stakes for credible work.
1. Regulators caught up
The SEC, PCAOB, and international standard-setters used 2020 as a stress test for fair value disclosure requirements. Still, the result? **More demanding disclosure expectations.And ** Vague "management estimates" language doesn't fly anymore. Registrants now need to explain which scenarios were weighted, why, and how key unobservable inputs were derived.
2. M&A contracts changed
Earnouts, collars, and working capital true-ups got more sophisticated. Buyers and sellers stopped arguing over a single number and started negotiating formulas — revenue thresholds tied to reopening milestones, EBITDA add-back definitions that explicitly address government aid, carve-outs for supply chain disruptions And that's really what it comes down to..
This changes depending on context. Keep that in mind Worth keeping that in mind..
3. The talent gap widened
Valuation teams that could model uncertainty well got promoted. Those that couldn't — or refused to move beyond "base case plus/minus 10%" — lost credibility. judgment-driven advisors**. The pandemic accelerated a split in the profession: **technical modelers vs. The latter are now the ones leading engagements And that's really what it comes down to..
How Valuation Methodologies Adapted in 2020
Let's walk through each major approach and what changed — practically — when the world locked down.
Discounted Cash Flow (DCF): The Forecast Nightmare
DCF is only as good as its inputs. In 2020, the inputs were garbage — or at least, highly speculative Surprisingly effective..
The terminal value trap
Terminal value often represents 60–80% of enterprise value in a DCF. In 2020, assuming a "normalized" Year 5 became an act of faith. Practitioners responded in three ways:
- Extended explicit forecast periods — 7–10 years instead of 5, to delay terminal value and force more near-term granularity.
- Scenario-based terminal values — different exit multiples or perpetuity growth rates for each scenario (V-shape, U-shape, L-shape recovery).
- Fade periods — explicit modeling of a 3–5 year "fade" from COVID-depressed margins to normalized levels, rather than a cliff-edge normalization.
Discount rate chaos
- Risk-free rate: 10-year Treasury dropped from ~1.9% (Jan 2020) to 0.5% (Aug 2020). Using a spot rate vs. a normalized rate became a material valuation driver.
- Equity risk premium (ERP): Implied ERP spiked to 6–7% in March (vs. 4.5–5% pre-COVID). Some firms used spot ERP; others used long-term averages. The spread mattered — a lot.
- Beta: Levered betas for cyclical stocks exploded. Unlevering/relevering with distorted capital structures (drawdowns on revolvers, new debt) created noise. Many valuators switched to industry median unlevered betas and re-levered at target capital structures — ignoring actual 2020 make use of.
The "mid-year convention" debate
With cash flows highly front- or back-loaded depending on lockdown timing, the standard mid-year discounting assumption broke down. Some firms moved to monthly or quarterly discounting for 2020–2021 cash flows, then reverted to annual Surprisingly effective..
Comparable Company Analysis: When Comps Stop Comparable
Trading comps are supposed to reflect "what the market pays for similar assets." In 2020, the market priced survival, not similarity Nothing fancy..
The "COVID discount" problem
Two identical companies — one with a strong balance sheet, one highly levered — traded at vastly different multiples. The market wasn't valuing EBITDA; it was valuing liquidity runway.
Valuators adjusted by:
- Filtering comps by financial health — net debt/EBITDA, cash/burn rate, covenant headroom.
- Using "clean" multiples — EV/(
"clean" multiples — EV/(EBITDA-adjusted) or EV/(Revenue-adjusted) for sectors where earnings were temporarily distorted by government aid, furloughs, or one-time impairments. g.Metrics like price-to-liquidity ratios (e., EV/cash or EV/(cash + revolver availability)) gained prominence for distressed or cyclical names.
Sectoral divergence and thematic clustering
Traditional industry classifications blurred. In practice, airlines, restaurants, and retail became “high-yield credit stories” rather than operating businesses. Meanwhile, cloud software, logistics, and e-commerce were reclassified as “growth” or “defensive” sub-sectors. Analysts began clustering companies by exposure to remote work, supply chain resilience, or consumer behavior shifts rather than legacy NAICS codes Still holds up..
Precedent Transaction Analysis: Ghost Town or Distressed Deals?
M&A activity contracted sharply in Q2 2020, but deal-making didn’t stop. It evolved.
The “pre-COVID premium” effect
Transactions executed in 2020 traded at discounts to 2019 averages. On top of that, valuators addressed this by:
- Blending pre- and post-COVID multiples, weighting toward pre-pandemic data for stable sectors. On the flip side, - Adjusting control premiums downward to reflect heightened execution risk and financing uncertainty. - Including distressed transactions in datasets, but flagging them explicitly to avoid skewing normative benchmarks.
Rise of contingent consideration
Earn-outs, contingent value rights (CVRs), and earn-out-linked purchase price adjustments surged. Traditional precedent transactions assumed fixed consideration; 2020 deals baked in performance-linked payouts, complicating comparability. Analysts built models to isolate upfront equity value from option-like components.
Special Situations Valuation: Credit Markets Take the Wheel
For highly leveraged or distressed firms, equity value often hinged on credit outcomes rather than operational performance And that's really what it comes down to..
Distressed exchanges and haircut analysis
Companies issuing new debt to retire old obligations at deep discounts forced valuators to model debt-for-equity swaps and implied equity haircuts. The “value of the firm” split between debt and equity tranches became a core exercise, especially in sectors like energy and retail.
Government support as a valuation input
PPP loans, wage subsidies, and tax deferrals artificially inflated liquidity and margins. Think about it: analysts incorporated these as non-recurring inflows, stripping them out to assess underlying business viability. This was particularly critical in healthcare, education, and municipal sectors Turns out it matters..
Option pricing models for distressed equity
For firms trading below net cash value or facing binary outcomes (e.g.In real terms, , bankruptcy vs. recovery), real options frameworks gained traction. These models treated equity as a call option on distressed assets, incorporating volatility from macroeconomic uncertainty and sector-specific shocks Surprisingly effective..
Balance Sheet Emphasis: Asset-Based Valuation Returns
With cash flow projections unreliable, balance sheet metrics resurged Most people skip this — try not to..
Liquidation preferences and asset coverage
Private equity and hedge funds leaned heavily on net asset value (NAV) and liquidation analyses, especially for real estate, infrastructure, and manufacturing assets. The gap between book value and market value of PP&E widened dramatically, prompting more frequent impairment testing.
Cash runway modeling
Startups and leveraged firms were valued primarily on months of runway (cash + undrawn facilities ÷ burn rate). This metric became a proxy for survival probability, influencing both trading multiples and M&A bids.
Conclusion: A Paradigm Shift Toward Flexibility
The pandemic exposed the fragility of static valuation models.
